Website stats for Mrknewsroom - mrknewsroom.com
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of . These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guar...
mrknewsroom.com was registered 7 years 4 months ago. It is a domain having .com extension. It is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently, mrknewsroom.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | Not Applicable |
| Daily Pageviews: | Not Applicable |
Estimated Valuation
| Income Per Day: | $ 0.15 |
| Estimated Worth: | $ 8.95 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | Not Applicable |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
192.0.66.224
Hosted Country:
US
Location Latitude:
37.7484Location Longitude:
-122.414Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For mrknewsroom.com
Merck Announces FDA Approval for ERVEBO ... - Merck Vaccines
- https://www.merckvaccines.com/wp-content/uploads/sites/8/2020/03/MerckAnnouncesFDAApprovalforERVEBO®EbolaZaireVaccineLive.pdf
Dec 20, 2019 ... Published on Merck Newsroom Home (https://www.mrknewsroom.com) on 12/20/19 7:15 am EST. Merck Announces FDA Approval for ERVEBO® (Ebola.
Diagnosis & Tests for Melanoma - Virginia Cancer Institute
Aug 14, 2020 ... Merck website. Available at: https://www.mrknewsroom.com/news-release/oncology-newsroom/mercks-pivotal-keynote-006-study-first ...
FDA Approves Doravirine (Pifeltro) and New FDC With TDF/3TC ...
Aug 31, 2018 ... www.mrknewsroom.com; ClinicalTrials.gov. MK-8591 with doravirine and lamivudine in participants infected with HIV type 1 (MK-8591-011) ...
Pembrolizumab for the Treatment of Hepatocellular Carcinoma ...
... https://www.mrknewsroom.com/news-release/oncology/merck-provides-update-keynote-240-phase-3-study-keytruda-pembrolizumab-previou (accessed February 19, ...
We need a coronavirus vaccine — I just wish we could afford it ...
Mar 20, 2020 ... https://www.mrknewsroom.com... Ken • 1 year ago. Everyone knows what went wrong in South Africa... Guest • 1 year ago. Guest • 1 year ago.
FDA Approval of Anti-Cancer Drug | Mesothelioma Help
http://www.mrknewsroom.com/news-release/prescription-medicine-news/fda-approves-mercks-keytruda-pembrolizumab-adult-and-pediatr; Keytruda website
Theron Leonce (@TheronLeonce) | Stocktwits
Jul 9, 2020 ... Merck announcement listed below: https://www.mrknewsroom.com/newsroom/news-releases/news-details/2020/Merck-Announces-Appointment-of-Organon ...
FDA aprueba pembrolizumab en 1L de cáncer colorrectal MSI-H o ...
Jun 30, 2020 ... ... https://www.mrknewsroom.com/newsroom/news-releases/news-details/2020/FDA-Approves-Mercks-KEYTRUDA-pembrolizumab-for-First-Line-Treatment ...
FDA approves Dificid for C. difficile treatment in children - Healio
Jan 27, 2020 ... ... older. https://www.mrknewsroom.com/news-release/prescription-medicine-news/fda-approves-mercks-dificid-fidaxomicin-treat-clostridioides.
Pembrolizumab in Patients With Metastatic Breast Cancer With High ...
Apr 12, 2021 ... ... in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer. https://www.mrknewsroom.com/news-release/oncology/merck- ...
Media - Merck.com
Merck's online newsroom offers real-time news about Merck's prescription medicines, vaccines and consumer care products.
Trial Investigators Discuss FDA Draft Guidance on Master Protocols
Nov 30, 2018 ... ... September27, 2015. mrknewsroom.com/news-release/oncology-newsroom/new-data-keynote-028-mercks-trial-evaluating-keytruda-pembrolizumab-a.
Practice-Changing Advances in the Adjuvant Treatment of Melanoma
May 30, 2018 ... ... 2018. www.mrknewsroom.com/news-release/oncology/mercks-keytruda-pembrolizumab-significantly-improved-recurrence-free-survival-.
Access the 2020 Prioritisation Report - Medicines Patent Pool
- https://medicinespatentpool.org/uploads/2021/01/Prioritisation_Report_2020.pdf
21 https://www.mrknewsroom.com/news-release/research-and-development-news/merck-presents-early-evidence-extended-delivery-investiga.
oup_inthea_ihx038 3..6 ++ - Oxford Academic Journals
http://www.mrknewsroom.com/news-release/ · corporate-news/merck-and-mectizan-donation-program-donate-1- · million-end-fund-efforts-he [accessed 1 June 2017]. 14 ...
The Nobel Prize: Checkpoint Inhibitors
Oct 18, 2018 ... mrknewsroom.com/news-release/prescription-medicine-news/merck-receives-accelerated-approv- 9. al-keytruda-pembrolizumab-f. Accessed October 2, ...
Pfizer and Merck's Steglatro for type 2 diabetes: a valuable...
Jun 7, 2018 ... 4 http://www.mrknewsroom.com/news-release/corporate-news/fda-approves-sglt2-inhibitor-steglatro-ertugliflozin-and-fixed-dose-comb.
HIV Clinical Updates: New Single-Tablet Regimens - Jamielynn C ...
... of HIV-1 infection. http://www.mrknewsroom.com/news-release/corporate-news/fda-accepts-new-drug-applications-mercks-doravirine-companys-investigati.
Published by HIV i-Base htb supplement: 2019 Vol 20:(1) New drugs ...
- http://i-base.info/htb/wp-content/uploads/2019/07/PIPELINE-2019-FINAL-full-version.pdf
Jul 10, 2019 ... https://www.mrknewsroom.com. 5. Merck (MSD) press release. FDA approves Merck's Delstrigo (doravirine/ lamivudine/tenofovir disoproxil ...
Odanacatib: the best osteoporosis treatment we never had? - The ...
Oct 29, 2019 ... Merck provides update on odanacatib development program.Sept 2, 2016. Merck Newsroom Home. https://www.mrknewsroom.com/news-release/research-and ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 3 | H2 Headings: | 4 |
| H3 Headings: | 11 | H4 Headings: | 1 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 23 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| of the | 9 | 0.735 % | No |
| 2021 Merck | 8 | 0.654 % | No |
| in the | 8 | 0.654 % | No |
| United States | 5 | 0.408 % | No |
| the United | 5 | 0.408 % | No |
| the company’s | 5 | 0.408 % | No |
| States and | 4 | 0.327 % | No |
| of Merck | 4 | 0.327 % | No |
| Merck Co | 4 | 0.327 % | No |
| KEYTRUDA® pembrolizumab | 4 | 0.327 % | No |
| Co Inc | 4 | 0.327 % | No |
| Oncologic Drugs | 3 | 0.245 % | No |
| Drugs Advisory | 3 | 0.245 % | No |
| health care | 3 | 0.245 % | No |
| products and | 3 | 0.245 % | No |
| Advisory Committee | 3 | 0.245 % | No |
| and Canada | 3 | 0.245 % | No |
| releases Company | 3 | 0.245 % | No |
| News releases | 3 | 0.245 % | No |
| Company statements | 3 | 0.245 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| the United States and | 4 | 0.327 % | No |
| of Merck Co Inc | 3 | 0.245 % | No |
| in the United States | 3 | 0.245 % | No |
| United States and Canada | 3 | 0.245 % | No |
| Oncologic Drugs Advisory Committee | 3 | 0.245 % | No |
| Inc Kenilworth NJ USA | 3 | 0.245 % | No |
| Co Inc Kenilworth NJ | 3 | 0.245 % | No |
| Merck Co Inc Kenilworth | 3 | 0.245 % | No |
| Drugs Advisory Committee ODAC | 2 | 0.163 % | No |
| 2021 Merck Statement on | 2 | 0.163 % | No |
| News releases Company statements | 2 | 0.163 % | No |
| differ materially from those | 2 | 0.163 % | No |
| in the forwardlooking statements | 2 | 0.163 % | No |
| of the United States | 2 | 0.163 % | No |
| FDA’s Oncologic Drugs Advisory | 2 | 0.163 % | No |
| NJ USA This news | 1 | 0.082 % | No |
| This news release of | 1 | 0.082 % | No |
| Kenilworth NJ USA This | 1 | 0.082 % | No |
| USA This news release | 1 | 0.082 % | No |
| reserved Forwardlooking statement of | 1 | 0.082 % | No |
Mobile Friendly Check
Mobile Friendly : Unknown
Score : Unknown
No data to show.
Websites Hosted on Same IP (i.e. 192.0.66.224)
Industrial Automation Tooling Systems & Products | ATS Automation
ATS Automation's industrial automation systems provide the perfect synergy of experience, automation technology & scale. Advance your factory automation today.
162,586 
$ 76,800.00
Página principal - MSD Salud Animal México
MSD Salud Animal es una empresa global, enfocada en la investigación, el desarrollo y manufactura de medicamentos y servicios veterinarios.
1,430,082 $ 960.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Sun, 25 Jul 2021 07:32:30 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 20444
Connection: keep-alive
Host-Header: a9130478a60e5f9135f765b23f26593b
X-Frame-Options: DENY
Link:
Content-Encoding: gzip
X-rq: hhn2 0 4 9980
Age: 223
X-Cache: hit
Cache-Control: private, no-store
Accept-Ranges: bytes
Strict-Transport-Security: max-age=31536000;includeSubdomains;preload
Domain Information
| Domain Registrar: |
MarkMonitor Inc.
|
|---|---|
| Registration Date: | 2017-02-07 7 years 4 months 3 weeks ago |
| Last Modified: | 2020-01-06 4 years 5 months 3 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| cbru.br.ns.els-gms.att.net | |
68.94.156.132 | United States |
| cmtu.mt.ns.els-gms.att.net | |
99.99.99.132 | United States |
| ns6.customer.level3.net | |
209.244.4.85 | United States |
| ns9.customer.level3.net | |
209.244.4.148 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| mrknewsroom.com | A | 296 |
IP: 192.0.66.224 |
| mrknewsroom.com | NS | 86400 |
Target: ns9.customer.level3.net |
| mrknewsroom.com | NS | 86400 |
Target: cbru.br.ns.els-gms.att.net |
| mrknewsroom.com | NS | 86400 |
Target: cmtu.mt.ns.els-gms.att.net |
| mrknewsroom.com | NS | 86400 |
Target: ns6.customer.level3.net |
| mrknewsroom.com | SOA | 86400 |
MNAME: cbru.br.ns.els-gms.att.net RNAME: rm-hostmaster.ems.att.com Serial: 12 Refresh: 3600 Retry: 1200 Expire: 604800 |
| mrknewsroom.com | TXT | 86400 |
TXT: v=spf1 -all |
Alexa Traffic Rank
Alexa Search Engine Traffic
Full WHOIS Lookup
Registry Domain ID:
2095948720_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.markmonitor.com
Registrar URL:
http://www.markmonitor.com
Updated Date:
2020-01-06T10:09:07Z
Creation Date:
2017-02-07T04:21:50Z
Registry Expiry Date:
2022-02-07T04:21:50Z
Registrar: MarkMonitor Inc.
Registrar
IANA ID: 292
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.2083895740
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
CBRU.BR.NS.ELS-GMS.ATT.NET
Name Server:
CMTU.MT.NS.ELS-GMS.ATT.NET
Name Server:
NS6.CUSTOMER.LEVEL3.NET
Name Server:
NS9.CUSTOMER.LEVEL3.NET
DNSSEC: unsigned
URL of the ICANN
Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>>
Last update of whois database: 2021-07-25T07:32:14Z
Similarly Ranked Websites
Google Chrome - Download the Fast, Secure Browser from Google
Get more done with the new Google Chrome. A more simple, secure, and faster web browser than ever, with Google’s smarts built-in. Download now.
1 $ 16,097,351,400.00
腾讯网
腾讯网从2003年创立至今，已经成为集新闻信息，区域垂直生活服务、社会化媒体资讯和产品为一体的互联网媒体平台。腾讯网下设新闻、科技、财经、娱乐、体育、汽车、时尚等多个频道，充分满足用户对不同类型资讯的需求。同时专注不同领域内容，打造精品栏目，并顺应技术发展趋势，推出网络直播等创新形式，改变了用户获取资讯的方式和习惯。
5 $ 3,219,470,280.00
Amazon.com. Spend less. Smile more.
- amazon.com
Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and...
8 $ 2,012,168,520.00
- instagram.com
Create an account or log in to Instagram - A simple, fun & creative way to capture, edit & share photos, videos & messages with friends & family.
9 $ 1,788,594,480.00